A Blend of Chlorophytum Borivilianum and Velvet Bean Increases Serum Growth Hormone in Exercise-Trained Men

Nutrition and Metabolic Insights

Volumn 4, Issue , 2011, Pages

  Alleman, Rick J ^a   Canale, Robert E ^a   McCarthy, Cameron G ^a   Bloomer, Richard J ^a  

^a UNIVERSITY OF MEMPHIS   (United States)

Author keywords

Chlorophytum borivilianum; growth hormone; Mucuna pruriens; supplements; Velvet bean

Indexed keywords

EID: 84898702571     PISSN: None     EISSN: 11786388     Source Type: Journal    
DOI: 10.4137/NMI.S8127     Document Type: Article

References (58)

1. Giustina A., Veldhuis J.D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998; 19(6): 717–97.
2. Hartman M.L., Veldhuis J.D., Thorner M.O. Normal control of growth hormone secretion. Horm Res. 1993; 40(1-3): 37–47.
3. Norrelund H. The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm IGF Res. 2005; 15(2): 95–122.
4. Ho K.Y., Evans W.S., Blizzard R.M. et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 1987; 64(1): 51–8.
5. Finkelstein J.W., Roffwarg H.P., Boyar R.M., Kream J., Hellman L. Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab. 1972; 35(5): 665–70.
6. Takahashi Y., Kipnis D.M., Daughaday W.H. Growth hormone secretion during sleep. J Clin Invest. 1968; 47(9): 2079–90.
7. Davidson J.R., Moldofsky H., Lue F.A. Growth hormone and cortisol secretion in relation to sleep and wakefulness. J Psychiatry Neurosci. 1991; 16(2): 96–102.
8. Ho K.Y., Veldhuis J.D., Johnson M.L. et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest. 1988; 81(4): 968–75.
9. Muller A.F., Lamberts S.W., Janssen J.A. et al. Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol. 2002; 146(2): 203–7.
10. Hojlund K., Wildner-Christensen M., Eshoj O. et al. Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting. Am J Physiol Endocrinol Metab. 2001; 280(1): E50–8.
11. Valimaki M., Tuominen J.A., Huhtaniemi I., Ylikahri R. The pulsatile secretion of gonadotropins and growth hormone, and the biological activity of luteinizing hormone in men acutely intoxicated with ethanol. Alcohol Clin Exp Res. 1990; 14(6): 928–31.
12. Chang F.E., Dodds W.G., Sullivan M., Kim M.H., Malarkey W.B. The acute effects of exercise on prolactin and growth hormone secretion: Comparison between sedentary women and women runners with normal and abnormal menstrual cycles. J Clin Endocrinol Metab. 1986; 62(3): 551–6.
13. Consitt L.A., Bloomer R.J., Wideman L. The effect of exercise type on immunofunctional and traditional growth hormone. Eur J Appl Physiol. 2007; 100(3): 321–30.
14. Lin T., Tucci J.R. Provocative tests of growth-hormone release. A comparison of results with seven stimuli. Ann Intern Med. 1974; 80(4): 464–9.
15. VanderLaan W.P. Changing concepts on the control of growth hormone secretion in man. Calif Med. 1971; 115(2): 38–46.
16. Quabbe H.J., Schilling E., Helge H. Pattern of growth hormone secretion during a 24-hour fast in normal adults. J Clin Endocrinol Metab. 1966; 26(10): 1173–7.
17. Goldsmith S.J., Glick S.M. Rhythmicity of human growth hormone secretion. Mt Sinai J Med. 1970; 37(4): 501–9.
18. Merimee T.J., Lillicrap D.A., Rabinowitz D. Effect of arginine on serum-levels of human growth-hormone. Lancet. 1965; 2(7414): 668–70.
19. Gagliardino J.J., Bailey J.D., Martin J.M. Effect of vasopressin on serum-levels of human growth hormone. Lancet. 1967; 1(7504): 1357–8.
20. Frohman L.A., Horton E.S., Lebovitz H.E. Growth hormone releasing action of a pseudomonas endotoxin (piromen). Metabolism. 1967; 16(1): 57–67.
21. Thakur G.S., Bag M., Sanodiya B.S. et al. Chlorophytum borivilianum: A white gold for biopharmaceuticals and neutraceuticals. Curr Pharm Biotechnol. 2009; 10(7): 650–66.
22. Kenjale R.D., Shah R.K., Sathaye S.S. Anti-stress and anti-oxidant effects of roots of chlorophytum borivilianum (santa pau & fernandes). Indian J Exp Biol. 2007; 45(11): 974–9.
23. Shukla K.K., Mahdi A.A., Ahmad M.K., Jaiswar S.P., Shankwar S.N., Tiwari S.C. Mucuna pruriens reduces stress and improves the quality of semen in infertile men. Evid Based Complement Alternat Med. 2010; 7(1): 137–44.
24. Thakur M., Bhargava S., Dixit V.K. Immunomodulatory activity of chlorophytum borivilianum sant. F. Evid Based Complement Alternat Med. 2007; 4(4): 419–23.
25. Kumar M., Meena P., Verma S., Kumar M., Kumar A. Anti-tumour, anti-mutagenic and chemomodulatory potential of chlorophytum borivilianum. Asian Pac J Cancer Prev. 2010; 11(2): 327–34.
26. Thakur M., Bhargava S., Praznik W., Loeppert R., Dixit V.K. Effect of chlorophytum borivilianum santapau and fernandes on sexual dysfunction in hyperglycemic male rats. Chin J Integr Med. 2009; 15(6): 448–53.
27. Kenjale R., Shah R., Sathaye S. Effects of chlorophytum borivilianum on sexual behaviour and sperm count in male rats. Phytother Res. 2008; 22(6): 796–801.
28. Visavadiya N.P., Narasimhacharya A.V. Ameliorative effect of chlorophytum borivilianum root on lipid metabolism in hyperlipaemic rats. Clin Exp Pharmacol Physiol. 2007; 34(3): 244–9.
29. Manyam B.V., Sanchez-Ramos J.R. Traditional and complementary therapies in parkinson's disease. Adv Neurol. 1999; 80: 565–74.
30. Katzenschlager R., Evans A., Manson A. et al. Mucuna pruriens in parkinson's disease: A double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004; 75(12): 1672–7.
31. An alternative medicine treatment for parkinson's disease: Results of a multicenter clinical trial. HP-200 in parkinson's disease study group. J Altern Complement Med. 1995; 1(3): 249–55.
32. Pugalenthi M., Vadivel V., Siddhuraju P. Alternative food/feed perspectives of an underutilized legume mucuna pruriens var utilis—a review. Plant Foods Hum Nutr. 2005; 60(4): 201–18.
33. Weldon V.V., Gupta S.K., Haymond M.W., Pagliara A.S., Jacobs L.S., Daughaday W.H. The use of L-DOPA in the diagnosis of hyposomatotropism in children. J Clin Endocrinol Metab. 1973; 36(1): 42–6.
34. Boyd AE 3rd, Lebovitz H.E., Pfeiffer J.B. Stimulation of human-growth-hormone secretion by L-dopa. N Engl J Med. 1970; 283(26): 1425–9.
35. Eddy R.L., Jones A.L., Chakmakjian Z.H., Silverthorne M.C. Effect of levodopa (L-DOPA) on human hypophyseal tropic hormone release. J Clin Endocrinol Metab. 1971; 33(4): 709–12.
36. Hayek A., Crawford J.D. L-DOPA and pituitary hormone secretion. J Clin Endocrinol Metab. 1972; 34(5): 764–6.
37. Kansal P.C., Buse J., Talbert O.R., Buse M.G. The effect of L-dopa on plasma growth hormone, insulin, and thyroxine. J Clin Endocrinol Metab. 1972; 34(1): 99–105.
38. Hussain G., Manyam B.V. Mucuna pruriens proves more effective than L-dopa in parkinson's disease animal model. Phytother Res. 1997; 11: 419–23.
39. Mahajani S.S., Doshi V.J., Parikh K.M. Bioavailability of L-DOPA from HP-200—a formulation of seed powder of mucuna pruriens (BAK): A pharmacokinetic and pharmacodynamic study. Phytother Res. 1996; 10: 254–6.
40. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003; 28(7): 916–31.
41. Syrotuik D.G., Bell G.J. Acute creatine monohydrate supplementation: A descriptive physiological profile of responders vs. nonresponders. J Strength Cond Res. 2004; 18(3): 610–7.
42. Bloomer R.J., Smith W.A., Fisher-Wellman K.H. Glycine propionyl-L-carnitine increases plasma nitrate/nitrite in resistance trained men. J Int Soc Sports Nutr. 2007; 4: 22.
43. Clarkson P.M., Rawson E.S. Nutritional supplements to increase muscle mass. Crit Rev Food Sci Nutr. 1999; 39(4): 317–28.
44. Merimee T.J., Rabinowtitz D., Fineberg S.E. Arginine-initiated release of human growth hormone factors modifying the response in normal man. N Engl J Med. 1969; 280(26): 1434–8.
45. Besset A., Bonardet A., Rondouin G., Descomps B., Passouant P. Increase in sleep related GH and prl secretion after chronic arginine aspartate administration in man. Acta Endocrinol (Copenh). 1982; 99(1): 18–23.
46. Parr T.B. A new technique to elevate night time growth hormone release and a potential growth hormone feedback control loop. Med Hypotheses. 2001; 56(5): 610–3.
47. di Luigi L., Guidetti L., Pigozzi F. et al. Acute amino acids supplementation enhances pituitary responsiveness in athletes. Med Sci Sports Exerc. 1999; 31(12): 1748–54.
48. Muller E.E., Brambilla F., Cavagnini F., Peracchi M., Panerai A. Slight effect of L-tryptophan on growth hormone release in normal human subjects. J Clin Endocrinol Metab. 1974; 39(1): 1–5.
49. Powers M.E., Yarrow J.F., McCoy S.C., Borst S.E. Growth hormone isoform responses to GABA ingestion at rest and after exercise. Med Sci Sports Exerc. 2008; 40(1): 104–10.
50. Matsuoka T., Kawanaka M., Nagai K. Effect of cytidine diphosphate choline on growth hormone and prolactin secretion in man. Endocrinol Jpn. 1978; 25(1): 55–7.
51. Ceda G.P., Ceresini G., Denti L. et al. Alpha-glycerylphosphorylcholine administration increases the GH responses to GHRH of young and elderly subjects. Horm Metab Res. 1992; 24(3): 119–21.
52. Baumann G., Stolar M.W. Molecular forms of human growth hormone secreted in vivo: Nonspecificity of secretory stimuli. J Clin Endocrinol Metab. 1986; 62(4): 789–90.
53. Barbieri C., Ferrari C., Caldara R., Curtarelli G. Growth hormone secretion in hypertensive patients: Evidence for a derangement in central adrenergic function. Clin Sci (Lond). 1980; 58(2): 135–8.
54. Syvalahti E., Pynnonen S. Secretion of human growth hormone and insulin in levodopa test during carbamazepine therapy. Acta Pharmacol Toxicol (Copenh). 1977; 40(2): 285–8.
55. Laurian L., Oberman Z., Ayalon D. et al. Under-responsiveness of growth hormone secretion after L-dopa and deep sleep stimulation in obese subjects. Isr J Med Sci. 1975; 11(5): 482–7.
56. Kumar M., Meena P., Verma S., Kumar M., Kumar A. Anti-tumour, anti-mutagenic and chemomodulatory potential of Chlorophytum borivilianum. Asian Pac J Cancer Prev. 2010; 11(2): 327–34.
57. An alternative medicine treatment for Parkinson's disease: results of a multicenter clinical trial. HP-200 in Parkinson's Disease Study Group. J Altern Complement Med. 1995 Fall; 1(3): 249–55.
58. Tharakan B., Dhanasekaran M., Mize-Berge J., Manyam B.V. Anti-Parkinson botanical Mucuna pruriens prevents levodopa induced plasmid and genomic DNA damage. Phytother Res. 2007 Dec; 21(12): 1124–6.